BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17353667)

  • 1. Biomarker discovery using high-dimensional lipid analysis.
    Wiest MM; Watkins SM
    Curr Opin Lipidol; 2007 Apr; 18(2):181-6. PubMed ID: 17353667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical strategies in lipidomics and applications in disease biomarker discovery.
    Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics strategies for the analysis of lipids.
    Wheelock CE; Goto S; Yetukuri L; D'Alexandri FL; Klukas C; Schreiber F; Oresic M
    Methods Mol Biol; 2009; 580():339-68. PubMed ID: 19784609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on lipidomics: progress and application in biomarker and drug development.
    Han X
    Curr Opin Mol Ther; 2007 Dec; 9(6):586-91. PubMed ID: 18041669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging field of lipidomics.
    Wenk MR
    Nat Rev Drug Discov; 2005 Jul; 4(7):594-610. PubMed ID: 16052242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidomics.
    Postle AD
    Curr Opin Clin Nutr Metab Care; 2012 Mar; 15(2):127-33. PubMed ID: 22316558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational biology for cardiovascular biomarker discovery.
    Azuaje F; Devaux Y; Wagner D
    Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alignment of LC-MS images, with applications to biomarker discovery and protein identification.
    Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B
    Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge discovery in metabolomics: an overview of MS data handling.
    Boccard J; Veuthey JL; Rudaz S
    J Sep Sci; 2010 Feb; 33(3):290-304. PubMed ID: 20087872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes and false discovery rate in microarray studies.
    Gusnanto A; Calza S; Pawitan Y
    Curr Opin Lipidol; 2007 Apr; 18(2):187-93. PubMed ID: 17353668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted metabolomics for biomarker discovery.
    Griffiths WJ; Koal T; Wang Y; Kohl M; Enot DP; Deigner HP
    Angew Chem Int Ed Engl; 2010 Jul; 49(32):5426-45. PubMed ID: 20629054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance proteomics as a tool in biomarker discovery.
    Meyer HE; Stühler K
    Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics.
    Sullards MC; Allegood JC; Kelly S; Wang E; Haynes CA; Park H; Chen Y; Merrill AH
    Methods Enzymol; 2007; 432():83-115. PubMed ID: 17954214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Literature review: considerations in undertaking focus group research with culturally and linguistically diverse groups.
    Halcomb EJ; Gholizadeh L; DiGiacomo M; Phillips J; Davidson PM
    J Clin Nurs; 2007 Jun; 16(6):1000-11. PubMed ID: 17518876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomics and lipid profiling in metabolomics.
    German JB; Gillies LA; Smilowitz JT; Zivkovic AM; Watkins SM
    Curr Opin Lipidol; 2007 Feb; 18(1):66-71. PubMed ID: 17218835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to dimensionality reduction in proteomic biomarker studies.
    Hilario M; Kalousis A
    Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics and computational methods for lipidomics.
    Niemelä PS; Castillo S; Sysi-Aho M; Oresic M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2855-62. PubMed ID: 19200789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.